Bruker EVP exercises options, sells 2,000 shares
An executive of Bruker Corp exercised a long-standing stock option for 2,000 shares and sold all resulting shares on the same day under a Rule 10b5-1 trading plan.
Rhea-AI Filing Summary
Bruker Corp (BRKR) officer Mark Munch, Executive Vice President and President of Bruker Nano Inc., exercised options for 2,000 shares of common stock on September 15, 2026 at an exercise price of $22.19 per share and sold the 2,000 acquired shares at $52.87 per share the same day. The stock option, originally granted on October 4, 2016, fully covered these 2,000 shares and was reported as having no remaining balance after the exercise. The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
Positive
- None.
Negative
- None.
Insider Trade Summary
Exercise and Sale: 2,000 shares ($61K approx. pre-tax spread)
Exercise and Sale
3 txns
Insider
Munch Mark
Role
EXEC VP&PRES BRUKER NANO INC.
Sold
2,000 shs ($106K)
Approx. gross sale proceeds
$106K
Approx. exercise cost
$44K
Approx. pre-tax spread
$61K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Purchase) F2 | 2,000 | $0.00 | $0.00 |
| Exercise | Common Stock | 2,000 | $22.19 | $44K |
| Sale | Common Stock F1 | 2,000 | $52.87 | $106K |
Holdings After Transaction:
Stock Option (Right to Purchase) — 0 contracts (Direct);
Common Stock — 134,806 shares (Direct)
Footnotes (2)
- F1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- F2. The stock option granted to the Reporting Person on October 4, 2016 (the "Original Grant Date") vests on the first, second, third and fourth anniversaries of the Original Grant Date.
Key Figures
Shares acquired via option exercise: 2,000 shares
Option exercise price: $22.19 per share
Shares sold: 2,000 shares
+4 more
7 metrics
Shares acquired via option exercise
2,000 shares
Common stock acquired on September 15, 2026 through option exercise
Option exercise price
$22.19 per share
Exercise of stock option into 2,000 shares on September 15, 2026
Shares sold
2,000 shares
Common stock sale on September 15, 2026 following option exercise
Sale price
$52.87 per share
Sale of 2,000 shares of common stock on September 15, 2026
Net shares sold
2,000 shares
Shares sold exceeded purchased shares by 2,000 according to the Form 4 summary
Original option grant date
October 4, 2016
Date the reported stock option was originally granted
Option expiration date
October 4, 2026
Expiration date of the exercised stock option
Key Terms
Rule 10b5-1 trading plan, Stock option, Original Grant Date, exercise price
4 terms
Rule 10b5-1 trading plan regulatory
"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
Stock option financial
"The stock option granted to the Reporting Person on October 4, 2016 (the "Original Grant Date") vests on the first, second, third and fourth anniversaries of the Original Grant Date."
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
Original Grant Date financial
"The stock option granted to the Reporting Person on October 4, 2016 (the "Original Grant Date") vests on the first, second, third and fourth anniversaries of the Original Grant Date."
exercise price financial
"Common stock was acquired through option exercise at an exercise price per share and then sold the same day."
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Bruker Corp (BRKR) executive Mark Munch report on this Form 4?
He reported exercising options for 2,000 shares of Bruker common stock at $22.19 per share on September 15, 2026, and selling those 2,000 shares the same day at $52.87 per share.
What role does the reporting person hold at Bruker Corp (BRKR)?
The reporting person, Mark Munch, is an officer of Bruker, serving as Executive Vice President and President of Bruker Nano Inc. as disclosed in the Form 4.
At what prices were the Bruker (BRKR) transactions reported on September 15, 2026?
The option was exercised at an exercise price of $22.19 per share, and the resulting 2,000 shares of common stock were sold at $52.87 per share on September 15, 2026.
Was the Bruker (BRKR) stock sale by Mark Munch under a Rule 10b5-1 plan?
Yes. The Form 4 footnote states that the sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person, indicating the transactions were pre-arranged under that plan.
What stock option did the Bruker (BRKR) executive exercise?
He exercised a stock option for 2,000 shares of Bruker common stock, originally granted on October 4, 2016. The option vested in four annual installments on the first through fourth anniversaries of the original grant date.
Are any options from this grant reported as remaining for the Bruker (BRKR) officer?
No. The Form 4 shows that after exercising 2,000 option shares, the reported balance of that option position was zero shares following the transaction.
AI-generated analysis. How Rhea-AI works. Not financial advice.
